Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Biondani · SciRah

Researcher profile · Semantic Scholar

P. Biondani

Share profile

P. Biondani — researcher profile on SciRah

h-index: 15
Works: 56
Citations: 1,082

Most-cited papers

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
J. Mazières, G. Zalcman, L. Crinò, P. Biondani +21 more
2015Journal of Clinical Oncology349 citations Open access
Semantic Scholar
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.
F. Pietrantonio, F. Perrone, F. De Braud, A. Castano +10 more
2014Annals of Oncology79 citations Open access
Semantic Scholar
Everolimus in combination with octreotide long‐acting repeatable in a first‐line setting for patients with neuroendocrine tumors: An ITMO group study
E. Bajetta, L. Catena, N. Fazio, S. Pusceddu +9 more
2014Cancer71 citations
Semantic Scholar
A review on biomarkers for prediction of treatment outcome in gastric cancer.
F. Pietrantonio, F. De Braud, V. Da Prat, F. Perrone +7 more
2013Anticancer Research64 citations
Semantic Scholar
The influence of maternal passive and light active smoking on intrauterine growth and body composition of the newborn
A. Luciano, M. Bolognani, P. Biondani, C. Ghizzi +2 more
1998European Journal of Clinical Nutrition54 citations Open access
Semantic Scholar
Role of cMET in the Development and Progression of Colorectal Cancer
J. S. Pérez-Vargas, P. Biondani, C. Maggi, M. Gariboldi +9 more
2013International Journal of Molecular Sciences53 citations Open access
Semantic Scholar
Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient.
P. Biondani, E. De Martin, D. Samuel
2018Annals of Oncology49 citations Open access
Semantic Scholar
Is the Standardized Uptake Value of FDG-PET/CT Predictive of Pathological Complete Response in Locally Advanced Rectal Cancer Treated with Capecitabine-Based Neoadjuvant Chemoradiation?
C. Bampo, A. Alessi, S. Fantini, G. Bertarelli +11 more
2013Oncology33 citations
Semantic Scholar
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
F. Pietrantonio, G. Aprile, L. Rimassa, P. Franco +20 more
2015Radiotherapy and Oncology32 citations
Semantic Scholar
Activity of epidermal growth factor tyrosine kinase inhibitors in non-small cell lung carcinoma with refractory leptomeningeal metastases.
R. Flippot, P. Biondani, É. Auclin, D. Xiao +16 more
2019Journal of Thoracic Oncology31 citations Open access
Semantic Scholar
Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens
F. Pietrantonio, F. Perrone, P. Biondani, C. Maggi +14 more
2013Cancer Biology & Therapy29 citations Open access
Semantic Scholar
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
F. Pietrantonio, V. Mazzaferro, R. Miceli, C. Cotsoglou +11 more
2015Medical Oncology27 citations
Semantic Scholar
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
S. Zuliani, I. Zampiva, D. Tregnago, M. Casali +51 more
2020European Journal of Cancer25 citations Open access
Semantic Scholar
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib
M. Del Re, S. Crucitta, C. Omarini, I. Bargagna +16 more
2022Breast21 citations Open access
Semantic Scholar
Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen.
F. Pietrantonio, P. Biondani, F. De Braud, A. Pellegrinelli +4 more
2012Translational Oncology19 citations Open access
Semantic Scholar
A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
A. Ulusakarya, A. Karaboué, O. Ciacio, G. Pittau +6 more
2020BMC Cancer15 citations Open access
Semantic Scholar
Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma
A. Ulusakarya, Nahla Teyar, A. Karaboué, M. Haydar +6 more
2019Medicine15 citations Open access
Semantic Scholar
Safety profile and treatment response of everolimus in different solid tumors: an observational study.
E. Verzoni, S. Pusceddu, R. Buzzoni, E. Garanzini +7 more
2014Future Oncology13 citations
Semantic Scholar
TP53 Mutations in Advanced Colorectal Cancer: The Dark Side of the Moon
F. Pietrantonio, P. Biondani, F. Perrone, M. Di Bartolomeo +8 more
2014Oncology12 citations
Semantic Scholar
Pharmacogenomics and Personalized Medicine Dovepress Targeted Treatments in Advanced Renal Cell Carcinoma: Focus on Axitinib
E. Verzoni, P. Grassi, I. Testa, R. Iacovelli +4 more
12 citations
Semantic Scholar
Chronomodulated Capecitabine and Adjuvant Radiation in Intermediate-risk to High-risk Rectal Cancer: A Phase II Study
E. Bajetta, F. Pietrantonio, R. Buzzoni, E. Ferrario +8 more
2014American Journal of Clinical Oncology11 citations
Semantic Scholar
Rationale and Protocol of Resort, a Randomized, Open-label, Multicenter Phase II Study to Evaluate the Efficacy of Sorafenib in Patients with Advanced Renal Cell Carcinoma after Radical Resection of the Metastases
G. Procopio, E. Verzoni, P. Biondani, P. Grassi +3 more
2014Tumori10 citations
Semantic Scholar
Patients aged over 75 years enrolled in Phase I clinical trials: the Gustave Roussy experience
C. Helissey, P. Biondani, F. Roquet, E. Lanoy +11 more
2016International Journal of Cancer9 citations Open access
Semantic Scholar
Role of BAX for outcome prediction in gastrointestinal malignancies
F. Pietrantonio, P. Biondani, E. Ciurlia, G. Fanetti +11 more
2013Medical Oncology9 citations
Semantic Scholar
Everolimus in combination with octreotide LAR as the first-line treatment for advanced neuroendocrine tumors: A phase II trial of the I.T.M.O. (Italian Trials in Medical Oncology) group.
E. Bajetta, L. Catena, N. Fazio, S. Pusceddu +11 more
20136 citations
Semantic Scholar
Efficacy of crizotinib in ROS1-rearranged lung cancer: The European experience.
J. Mazières, G. Zalcman, L. Crinò, P. Biondani +16 more
20145 citations
Semantic Scholar
Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patients.
P. Biondani, E. Verzoni, V. Torri, L. Porcu +4 more
2014Anticancer Research5 citations
Semantic Scholar
Activity of a three-drug combination including cisplatin (CLOVER regimen) for poorly differentiated neuroendocrine carcinoma.
E. Bajetta, L. Catena, P. Biondani, S. Pusceddu +3 more
2014Anticancer Research4 citations
Semantic Scholar
Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumab
F. Pietrantonio, P. Biondani, A. Pellegrinelli, A. Marchianò +3 more
2012Medical Oncology4 citations
Semantic Scholar
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
S. Zanelli, E. Fiorio, I. Zampiva, F. Zacchi +12 more
2022Annals of Oncology3 citations Open access
Semantic Scholar
High pathologic response rate of hepatic colorectal cancer metastases (HCRM) following neoadjuvant bevacizumab (Bev)-based treatment (tx).
F. Pietrantonio, J. Coppa, R. Miceli, M. Milione +11 more
20133 citations
Semantic Scholar
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients
F. Pietrantonio, P. Biondani, M. Milione, F. Melotti +7 more
2013Clinical and Translational Oncology3 citations
Semantic Scholar
New Perspectives in Advanced Genitourinary Malignancies
P. Biondani, G. Procopio, F. Pietrantonio, F. De Braud +1 more
2012Tumori3 citations
Semantic Scholar
Adjuvant treatment of colorectal cancer in the elderly: Where do we come from and where are we going?
M. Di Bartolomeo, F. Pietrantonio, P. Biondani, F. De Braud
20122 citations Open access
Semantic Scholar
Patient-tailored FOLFIRINOX in the first-line treatment of patients (pts) with advanced pancreatic cancer (PC).
A. Ulusakarya, Nahla Teyar, A. Karaboué, M. Haydar +5 more
20181 citations
Semantic Scholar
Management of advanced genitourinary tumors.
F. Pietrantonio, P. Biondani, E. Verzoni, G. Procopio
2012Tumori1 citations
Semantic Scholar
6626 POSTER Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study
R. Buzzoni, S. Pusceddu, P. Biondani, M. Cantore +6 more
20111 citations
Semantic Scholar
Potential therapeutic implications of next generation sequencing (NGS)-based molecular profiling in HR+/HER2- metastatic breast cancer (mBC).
B. Avesani, E. Giontella, A. Caldart, Alessandro De Noni +16 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience
A. Caldart, E. Fiorio, S. Zanelli, P. Biondani +13 more
2022European Journal of Cancer0 citations
Semantic Scholar
A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
A. Ulusakarya, A. Karaboué, O. Ciacio, G. Pittau +6 more
2020BMC Cancer0 citations Open access
Semantic Scholar
P1.01-19 Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases
R. Flippot, É. Auclin, P. Biondani, É. Le Rhun +8 more
2018Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
144PD Leptomeningeal metastases in EGFR-mutated non-small cell lung carcinoma: Management after tyrosine kinase inhibitors
R. Flippot, É. Auclin, P. Biondani, É. Le Rhun +6 more
20180 citations Open access
Semantic Scholar
Gain of ALK gene copy number to predict lack of response to anti-EGFR treatment in advanced chemorefractory colorectal cancer (CRC) with KRAS/NRAS/BRAF/PI3KCA wild-type status.
F. Pietrantonio, A. Tessari, R. Miceli, P. Biondani +10 more
20170 citations
Semantic Scholar
Erratum: Safety profile and treatment response of everolimus in different solid tumors: An observational study (Future Oncology (2014) 10:9 (1611-1617))
E. Verzoni, S. Pusceddu, R. Buzzoni, E. Garanzini +7 more
20140 citations
Semantic Scholar
Contents Vol. 86, 2014
S. Hayman, Juan Calle, A. Jatoi, Iasmina M. Craici +148 more
2014Oncology0 citations Open access
Semantic Scholar
P035 Sequential targeted therapy with sunitinib-sorafenib (SU-SO) versus sorafenib-sunitinib (SO-SU) in metastatic renal cell carcinoma: Results from a large cohort of patients
P. Biondani, E. Verzoni, V. Torri, L. Porcu +2 more
20130 citations
Semantic Scholar
Future Directions in Metastatic Castration Resistant Prostate Cancer (mCRPC): Clinical Rationale and Use of New-Generation Hormonal Therapies
P. Grassi, E. Verzoni, R. Montone, I. Testa +5 more
20130 citations Open access
Semantic Scholar
Pathologic response, KRAS status, and bevacizumab: The Bermuda triangle for outcome prediction after hepatic colorectal cancer metastases (HCRM) resection.
G. Fanetti, P. Biondani, A. Tessari, F. Melotti +8 more
20130 citations
Semantic Scholar
Role of FDG-PET as predictive biomarker of pathologic complete response (pCR) in locally advanced rectal cancer (LARC) treated with capecitabine-based neoadjuvant chemoradiation (NACR).
F. Pietrantonio, M. Di Bartolomeo, C. Bampo, F. Valvo +12 more
20120 citations
Semantic Scholar
Management of Advanced Genitourinary Tumors
P. Biondani, E. Verzoni, G. Procopio
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Pietrantonio×21
Invite
F. Pietrantonio — researcher profile on SciRah
M. Di Bartolomeo×19
Invite
M. Di Bartolomeo — researcher profile on SciRah
F. De Braud×18
Invite
F. De Braud — researcher profile on SciRah
F. Perrone×10
Invite
F. Perrone — researcher profile on SciRah

×10

Invite

E. Verzoni — researcher profile on SciRah

G. Procopio×10

Invite

G. Procopio — researcher profile on SciRah

Invite

M. Milione — researcher profile on SciRah

Invite

I. Bossi — researcher profile on SciRah

Invite

G. Fanetti — researcher profile on SciRah

Invite

L. Mariani — researcher profile on SciRah

Invite

S. Pusceddu — researcher profile on SciRah

Invite

F. Melotti — researcher profile on SciRah